Q2 revenue reached $33.7M, with core product sales down 19% year-over-year amid competitive pressures. The Alcon collaboration brought $6.5M in milestone revenue and will contribute $30M–$40M in 2026. Full-year guidance was withdrawn pending a business reassessment.Based on RxSight, Inc. [RXST] Q2…
Q2 revenue reached $33.7M, with core product sales down 19% year-over-year amid competitive pressures. The Alcon collaboration brought $6.5M in milestone revenue and will contribute $30M–$40M in 2026. Full-year guidance was withdrawn pending a business reassessment.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.